Evaluating the Success of Endovascular Treatment in Patients with Peripheral Artery Disease

Document Type: Original article

Authors

Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Background: Atherosclerosis is a systemic disease of large- and medium-sized arteries in which the diameter of the artery is narrowed due to accumulation of fat and fibrous materials between the intima and medial layers of the vessels. Atherosclerosis of non-cardiac arteries is called Peripheral Artery Disease (PAD). Although endovascular treatments demonstrated high success rates, treatment failure is still regarded as a great concern. Therefore, the purpose of this study was to evaluate the success rates and risk factors of Percutaneous Transluminal Angioplasty (PTA) in patients with PAD.
Methods: In this retrospective cohort study, the medical records of all the patients referring to Shariati Hospital and Tehran Heart Center with complaints of severe claudication, treated via PTA during 2007-13 were collected from the archives. Required data were extracted from the records and then were analyzed by SPSS software V24.
Results: Of the 111 patients included in this study, 2 underwent PTA three times. Two PTAs were performed on 17 subjects and the rest only had one PTA. Based on the results, the first PTA in 96 patients (86.5%) was successful, in 12 subjects (10.8%) was acceptable and in three cases was unsuccessful. Considering the acceptable results as successful, a success rate of 97.3% was calculated. It was revealed that 17 subjects needed a second PTA which is indicative of a 15.7% re-stenosis rate. According to the analysis performed to identify the risk factors of treatment failure, the differences regarding length of the lesion (p<0.001) and serum HDL level (p=0.005) were statistically significant.
Conclusion: The success rate of PTA for treatment of PAD was found to be considerably high which promotes its application as the treatment of choice. However, the risk factors identified in this study seem to be accidental findings due to a small sample size of patients in one of our comparison groups.

Keywords


1. Goessens BM, van der Graaf Y, Olijhoek JK, Visseren FL, SMART Study Group. The course of vascular risk factors and the occurrence of vascular events in patients with symptomatic peripheral arterial disease. J Vasc Surg 2007;45(1):47-54.
2. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL,et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). Circulation 2006 Mar 21;113(11):e463-654.
3. Norgren L, Hiatt WR, Dormandy Ja, Nehler MR, Harris KA, Fowkes FGR, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007;45 Suppl S:S5-67.
4. Olin JW, Sealove BA, editors. Peripheral artery disease: current insight into the disease and its diagnosis and management. Mayo Clin Proc 2010;85(7):678–692.
5. European Stroke Organisation, Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clément D, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases. Eur Heart J 2011;32(22):2851-906.
6. Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK, et al. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2011;58(19):2020-45.
7. Novo S. Classification, epidemiology, risk factors, and natural history of peripheral arterial disease. Diabetes, Obesity and Metabolism 2002;4(s2):S1-S6.
8. Criqui M, Denenberg J, Langer R, Fronek A. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med 1996;2(3):221-6.
9. Allaqaband S, Kirvaitis R, Jan F, Bajwa T. Endovascular treatment of peripheral vascular disease. Curr Probl Cardiol 2009;34(9):359-476.
10. Diehm C, Schuster A, Allenberg JR, Darius H, Haberl R, Lange S, et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 2004;172(1):95-105.
11. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286(11):1317-24.
12. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States results from the national health and nutrition examination survey, 1999-2000. Circulation 2004;110(6):738-43.
13. Smith SC, Milani RV, Arnett DK, Crouse JR, McDermott MM, Ridker PM, et al. Atherosclerotic vascular disease conference writing group II: risk factors. Circulation 2004;109(21):2613-6.
14. Murabito JM, D’Agostino RB, Silbershatz H, Wilson PW. Intermittent claudication a risk profile from the Framingham heart study. Circulation 1997;96(1):44-9.
15. Ostchega Y, Pauloseā€Ram R, Dillon CF, Gu Q, Hughes JP. Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey 1999–2004. J Am Geriatr Soc 2007;55(4):583-9.
16. Reeder BA, Liu L, Horlick L. Sociodemographic variation in the prevalence of cardiovascular disease. Canadian J Cardiology 1996;12(3):271-7.
17. Murabito JM, Evans JC, Nieto K, Larson MG, Levy D, Wilson PW. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J 2002;143(6):961-5.
18. Pasternak RC, Criqui MH, Benjamin EJ, Fowkes FGR, Isselbacher EM, McCullough PA, et al. Atherosclerotic vascular disease conference writing group I: epidemiology. Circulation 2004;109(21):2605-12.
19. Kröger K, Stang A, Kondratieva J, Moebus S, Beck E, Schmermund A, et al. Prevalence of peripheral arterial disease–results of the Heinz Nixdorf recall study. Eur J Epidemiol 2006;21(4):279-85.
20. Agarwal S. The association of active and passive smoking with peripheral arterial disease: results from NHANES 1999-2004. Angiology 2009;60(3):335-45.
21. McDermott MM, Greenland P, Liu K, Criqui MH, Guralnik JM, Celic L, et al. Sex differences in peripheral arterial disease: leg symptoms and physical functioning. J Am Geriatr Soc 2003;51(2):222-8.
22. Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO, et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 1993;88(3):837-45.
23. Hirsch AT, Allison MA, Gomes AS, Corriere MA, Duval S, Ershow AG, et al. A call to action: women and peripheral artery disease a scientific statement from the American Heart Association. Circulation 2012;125(11):1449-72.
24. Brevetti G, Bucur R, Balbarini A, Melillo E, Novo S, Muratori I, et al. Women and peripheral arterial disease: same disease, different issues. J Cardiovasc Med (Hagerstown) 2008;9(4):382-8.
25. Meadows TA, Bhatt DL, Hirsch AT, Creager MA, Califf RM, Ohman EM, et al. Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: insights from the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Am Heart J 2009;158(6):1038-45.
26. Allison MA, Ho E, Denenberg JO, Langer RD, Newman AB, Fabsitz RR, et al. Ethnic-specific prevalence of peripheral arterial disease in the United States. Am J Prev Med 2007;32(4):328-33.
27. Gallino A, Mahler F, Probst P, Nachbur B. Percutaneous transluminal angioplasty of the arteries of the lower limbs: a 5 year follow-up. Circulation 1984;70(4):619-23.
28. Johnston KW, Rae M, Hogg-Johnston SA, Colapinto RF, Walker PM, Baird RJ, et al. 5-year results of a prospective study of percutaneous transluminal angioplasty. Ann Surg 1987;206(4):403-13.
29. Sullivan TM, Childs MB, Bacharach JM, Gray BH, Piedmonte MR. Percutaneous transluminal angioplasty and primary stenting of the iliac arteries in 288 patients. J Vasc Surg 1997;25(5):829-39.
30. Bonvini RF, Rastan A, Sixt S, Noory E, Schwarz T, Frank U, et al. Endovascular treatment of common femoral artery disease: medium-term outcomes of 360 consecutive procedures. J Am Coll Cardiol 2011;58(8):792-8.
31. Davies MG, Bismuth J, Saad WE, Naoum JJ, Peden EK, Lumsden AB. Outcomes of interventions for recurrent disease after endoluminal intervention for superficial femoral artery disease. J Vasc Surg 2010;52(2):331-9. e1-2.
32. Giugliano G, Perrino C, Schiano V, Brevetti L, Sannino A, Schiattarella GG, et al. Endovascular treatment of lower extremity arteries is associated with an improved outcome in diabetic patients affected by intermittent claudication. BMC Surg 2012;12(Suppl 1):S19.
33. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989;79(1):8-15.
34. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. Am J Med 1977;62(5):707-14.
35. Cambria RP, Faust G, Gusberg R, Tilson MD, Zucker KA, Modlin IM. Percutaneous angioplasty for peripheral arterial occlusive disease: correlates of clinical success. Arch Surg 1987;122(3):283-7.